Efficacy and Safety of GLP-1 Receptor Agonists, Dual Agonists, and Retatrutide for Weight Loss in Adults With Overweight or Obesity: A Bayesian Network Meta-Analysis
and our plans, expectations and objectives
There are three main mechanisms relevant to Canadian patients today, plus a group of older drugs that have largely fallen out of use: GLP-1 and related incretin drugs These mimic gut hormones that regulate appetite and blood sugar, reducing hunger and slowing digestion
TAD 2500 is a premium injectable glutathione formulation with an unmatched 2500 mg concentration per vial, making it one of the highest dose glutathione injectables available in the Philippine market today
Some of it is absolutely in our control, but factors like genetic predispositions may not be
The dual agonism targets both GIP and GLP-1 pathways, which are key incretin hormones involved in glucose regulation